| Revision as of 19:36, 27 October 2021 editSkyerise (talk | contribs)Extended confirmed users, Pending changes reviewers, Rollbackers141,243 edits →October 2021: my mistake← Previous edit | Revision as of 17:51, 11 November 2021 edit undoPAR (talk | contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers11,662 editsNo edit summaryNext edit → | ||
| Line 40: | Line 40: | ||
| :As you point out, I was mistaken in reading your edit as an addition. The real problem was that the sentence you were editing was off-topic in the etymology section, so I removed it. Feel free to integrate into a more appropriate place in the article. ] (]) 19:36, 27 October 2021 (UTC) | :As you point out, I was mistaken in reading your edit as an addition. The real problem was that the sentence you were editing was off-topic in the etymology section, so I removed it. Feel free to integrate into a more appropriate place in the article. ] (]) 19:36, 27 October 2021 (UTC) | ||
| == Ivermectin Article == | |||
| You reverted my edit to the Ivermectin article which provided three references, available from NIH, on the ability of Ivermectin to bind to the COVID-19 spike protein, indicating that it may be useful for treatment of the disease. Clinical trials are ongoing, and it is certainly not yet approved by the various agencies, but I think this information is useful. I think peer-reviewed articles from respectable journals, available at the National Institute of Health website do not qualify as "unreliable/misinformation". Here are the articles: | |||
| <ref name="Lehrer2020">{{cite journal |last1=Lehrer |first1=Steven |last2=Rheinstein |first2=Peter H. |date=Sep-Oct 2020 |title=Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2 |url=https://pubmed.ncbi.nlm.nih.gov/32871846/ |journal=In Vivo |volume=34 |issue=5 |pages= |doi=10.21873/invivo.12134|access-date=Nov 11, 2021}}</ref><ref name="Saha2021">{{cite journal |last1=Saha |first1=J. |last2=Raihan |first2=M. |date=2021 |title= The binding mechanism of ivermectin and levosalbutamol with spike protein of SARS-CoV-2 |url=https://pubmed.ncbi.nlm.nih.gov/33867777/|journal=Structural Chemistry |volume= |issue= |pages= |doi=10.1007/s11224-021-01776-0 |access-date=Nov 11, 2021}}</ref><ref name="Eweas2021">{{cite journal |last1=Eweas|first1=A.|last2=Alhossary |first2=A.|last3=Abdel-Moneim|first3=A.|date=25 Jan, 2021|title=Molecular docking reveals ivermectin and remdesivir as potential repurposed drugs against SARS-CoV-2 |url=https://pubmed.ncbi.nlm.nih.gov/33746908/|journal=Front. Microbiol. 11:592908 |volume= |issue= |pages= |doi=10.3389/fmicb.2020.592908 |access-date=Nov 11, 2021}}</ref> | |||
| Please let me know if this changes your opinion. ] (]) 17:51, 11 November 2021 (UTC) | |||
Revision as of 17:51, 11 November 2021
 Archives | ||
Index
|
||
|
This page has archives. Sections older than 90 days may be automatically archived by ClueBot III. |
MOS:FOREIGNITALIC in geta (footwear)
Hey, Ineffablebookkeeper, I see you formatted geta with {{lang}} last year (at some point someone redid the ja-Latn with {{transl}}). However, I was able to find an entry for geta in Merriam-Webster Online. I believe, then, that it has failed the rule of thumb for applying MOS:FOREIGNITALIC and should be treated as an English loanword. I removed {{transl}} from around it and zori for the same reason. I thought I should let you know since you did the MOS:LANG formatting originally. —I'llbeyourbeach (talk) 18:21, 14 August 2021 (UTC)
- Ah, thank you for letting me know! I watch a number of other pages that likely have those terms on them - I'll be sure to remove the transl tags when I next run into them. -- Ineffablebookkeeper (talk) 18:31, 14 August 2021 (UTC)
- Thank you so much! That'd be extremely helpful and kind. I did the same in zori's article too. —I'llbeyourbeach (talk) 04:22, 15 August 2021 (UTC)
Disambiguation link notification for August 19
An automated process has detected that when you recently edited Industrial espionage, you added a link pointing to the disambiguation page Britain.
(Opt-out instructions.) --DPL bot (talk) 05:59, 19 August 2021 (UTC)
MOSPOSS
Please don't make changes to the possessive form as you did here: This is contrary to MOS:POSS. Also please see Help:Edit summary. GA-RT-22 (talk) 17:04, 13 September 2021 (UTC)
- Ah - terribly sorry. I didn't know that MOS existed. -- Ineffablebookkeeper (talk) 17:56, 13 September 2021 (UTC)
Edit comments
Hi, if as at De materia medica you're making small formatting changes, i.e. even if you're not making substantial edits, please either mark these as minor (if within the rules for that) or give a brief edit comment (e.g. "tagging languages") as is good practice (and indeed policy), to save other editors from having to check for vandalism. Many thanks, Chiswick Chap (talk) 08:24, 23 October 2021 (UTC)
- @Chiswick Chap: - my apologies; I'll be sure to add a brief comment in future, though editing on mobile I'm unable to mark my edits as minor. I appreciate the horror of checking through a watchlist and thinking "oh God, what now"(!) - so I'll change my behaviour going forwards. --Ineffablebookkeeper (talk) 11:01, 23 October 2021 (UTC)
- Many thanks! Chiswick Chap (talk) 11:07, 23 October 2021 (UTC)
October 2021
Hello, I'm Skyerise. I noticed that you added or changed content in an article, Sacramental bread, but you didn't provide a reliable source. It's been removed and archived in the page history for now, but if you'd like to include a citation and re-add it, please do so. You can have a look at referencing for beginners. If you think I made a mistake, you can leave me a message on my talk page. Thank you. Skyerise (talk) 17:35, 27 October 2021 (UTC)
- As you point out, I was mistaken in reading your edit as an addition. The real problem was that the sentence you were editing was off-topic in the etymology section, so I removed it. Feel free to integrate into a more appropriate place in the article. Skyerise (talk) 19:36, 27 October 2021 (UTC)
Ivermectin Article
You reverted my edit to the Ivermectin article which provided three references, available from NIH, on the ability of Ivermectin to bind to the COVID-19 spike protein, indicating that it may be useful for treatment of the disease. Clinical trials are ongoing, and it is certainly not yet approved by the various agencies, but I think this information is useful. I think peer-reviewed articles from respectable journals, available at the National Institute of Health website do not qualify as "unreliable/misinformation". Here are the articles: Please let me know if this changes your opinion. PAR (talk) 17:51, 11 November 2021 (UTC)
- Lehrer, Steven; Rheinstein, Peter H. (Sep–Oct 2020). "Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2". In Vivo. 34 (5). doi:10.21873/invivo.12134. Retrieved Nov 11, 2021.
{{cite journal}}: CS1 maint: date format (link) - Saha, J.; Raihan, M. (2021). "The binding mechanism of ivermectin and levosalbutamol with spike protein of SARS-CoV-2". Structural Chemistry. doi:10.1007/s11224-021-01776-0. Retrieved Nov 11, 2021.
- Eweas, A.; Alhossary, A.; Abdel-Moneim, A. (25 Jan, 2021). "Molecular docking reveals ivermectin and remdesivir as potential repurposed drugs against SARS-CoV-2". Front. Microbiol. 11:592908. doi:10.3389/fmicb.2020.592908. Retrieved Nov 11, 2021.
{{cite journal}}: Check date values in:|date=(help)CS1 maint: unflagged free DOI (link)